Loading chat...
US SR477
Resolution
Status
Introduced
10/30/2025
Primary Sponsor
Markwayne Mullin
Click for details
AI Summary
- Designates the first full week in May as "Tardive Dyskinesia Awareness Week"
- Tardive dyskinesia (TD) is a condition causing uncontrollable, repetitive movements of the face, torso, and limbs, associated with prolonged antipsychotic medication use
- Approximately 60% of the estimated 800,000 adults living with TD in the United States remain undiagnosed
- Higher-risk populations include individuals over 55, Black individuals, women, those with mood or substance use disorders, intellectual disabilities, or central nervous system injuries
- Supports efforts to raise awareness about TD causes, symptoms, and the importance of routine screening for patients on antipsychotics
Legislative Description
A resolution designating the first full week in May as "Tardive Dyskinesia Awareness Week".
Health
Last Action
Referred to the Committee on the Judiciary. (text: CR S7851-7852)
10/30/2025
Committee Referrals
Judiciary10/30/2025
Full Bill Text
No bill text available